Mr. Agmon is a Biomed & Technology executive, with over 15 years of hands-on experience in evaluating, founding and managing Life Science-oriented ventures. Mr. Agmon also served as an independent consultant, guiding clients in strategic planning, fund-raising, and due-diligence.

Before Joining Prometheus, Mr. Agmon was a co-founder and Fund Manager of the Aviv Bio-Invest Fund, where he was responsible for strategic planning and execution as well as for analyzing and evaluating dozens of public biomed companies.

Prior to founding Aviv, Mr. Agmon served as the CEO of Meytav Technology Incubator, an early-stage accelerator specializes in life-sciences, with over 20 portfolio start-ups.

Over the years Mr. Agmon served as an active board member in numerous companies, including Kitov Pharmaceuticals Holdings Ltd. (Nasdaq: KTOV), and other med-tech companies.

Mr. Agmon holds a B.Sc in Life Science & Business Administration from the Tel Aviv University and an MBA in Business Administration (specializing in Marketing & Financing) from the Hebrew University in Jerusalem, Israel.